Publicaciones en colaboración con investigadores/as de German Center for Neurodegenerative Diseases (41)

2024

  1. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  2. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

    Brain Communications, Vol. 6, Núm. 4

  3. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

  4. Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials

    Movement Disorders, Vol. 39, Núm. 8, pp. 1329-1342

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  4. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1573-1586

  5. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  6. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

    Brain, Vol. 146, Núm. 1, pp. 321-336

  7. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1947-1962

2022

  1. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 11, pp. 1764-1777

  2. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  3. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

    Alzheimer's and Dementia, Vol. 18, Núm. 7, pp. 1408-1423

  4. Data-driven staging of genetic frontotemporal dementia using multi-modal MRI

    Human Brain Mapping, Vol. 43, Núm. 6, pp. 1821-1835

  5. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  6. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  7. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

    Cortex, Vol. 150, pp. 12-28

  8. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  9. Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study

    Annals of Neurology, Vol. 91, Núm. 1, pp. 33-47